SWELLING Symptoms and Causes

Edema means Swelling caused by fluid in your body's tissues. It usually occurs in the feet, ankles and legs, but it can involve your entire body.

Causes of edema include

  • Eating too much salt
  • Sunburn
  • Heart failure
  • Kidney disease
  • Liver problems from cirrhosis
  • Pregnancy
  • Problems with lymph nodes, especially after mastectomy
  • Some medicines
  • Standing or walking a lot when the weather is warm

To keep Swelling down, your health care provider may recommend keeping your legs raised when sitting, wearing support stockings, limiting how much salt you eat, or taking a medicine called a diuretic - also called a water pill.

Check out the latest treatments for SWELLING

SWELLING treatment research studies

RECLAST clinical trials, surveys and public health registries

Find Drug Side Effect reports

RECLAST Side Effects

Arthralgia (599)
Pain (418)
Myalgia (402)
Headache (341)
Bone Pain (334)
Pyrexia (332)
Influenza Like Illness (315)
Nausea (272)
Chills (241)
Asthenia (234)
Fatigue (233)
Back Pain (228)
Pain In Extremity (213)
Dizziness (181)
Dyspnoea (177)
Chest Pain (163)
Vomiting (163)
Malaise (141)
Gait Disturbance (136)
Diarrhoea (128)
Death (122)
Pain In Jaw (121)
Muscle Spasms (112)
Feeling Abnormal (101)
Abasia (99)
Musculoskeletal Pain (99)
Oedema Peripheral (98)
Blood Creatinine Increased (95)
Fall (89)
Joint Swelling (84)
Neck Pain (83)
Dehydration (79)
Confusional State (76)
Muscular Weakness (73)
Blood Pressure Increased (69)
Abdominal Pain (67)
Renal Failure Acute (67)
Musculoskeletal Stiffness (66)
Paraesthesia (66)
Hypoaesthesia (65)
Decreased Appetite (63)
Insomnia (60)
Erythema (59)
Eye Pain (58)
Chest Discomfort (57)
Atrial Fibrillation (56)
Activities Of Daily Living Impaired (55)
Hypocalcaemia (54)
Syncope (53)
Osteonecrosis (52)

➢ More

Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)

Recent Reviews

I just had the infusion two days ago (1/19/10) and was surprised with the intensity of muscle pain the day after the treatment. My pain was localized to my rib cage, neck, shoulders and upper back. In addition I was very fatiqued...slept most of

"Association does not equal causation": posters seem to assume that any symptom occurring within a year of the Reclast infusion is caused by Reclast (just noticing that, and wondering whether the manufacturer needs to do a better jo

<span style='color: #808080;'>i was very unsure about reclast but the specialist was very pushie about me tring it,when i read up on it everything negative ( as far as reviews) my doc said don't go by reviews.aftre 2 mths i

Tell women not to take this drug. I for see huge lawsuits in the future. I may not live that long but it will happen! I was told to report to the hospital for my infusion. No one told me mu

<span style='color: #808080;'><b>Describe Your Injection site swelling from INFLUENZA (H1N1) (H1N1 (MONOVALENT) (UNKNOWN)) 2010 Experience Here: I am 46, Female on discharge from hospital 12.6.10 10pm after treatment for acute diverticuli

<span style='color: #808080;'>si vous prenez le medrol 16 mg mangez des dattes et des bananes qui sont riches en potassium et n'oubliez pas de faire des analyses de temps en temps , une chute de potassium pourrait&ecirc;tre&nb

<strong></strong><span style='color: #808080;'>I had my first Reclast infusion last Thursday morning. I am a nurse so am on my feet a lot and at work Thursday evening I started having pain across the back of my

12 hours after Reclast IV, had fever, chills, pain in stomach, dizziness, headache - lasted 12 hours on and off - scary.

2 months after injection . I want to say I was extremely ill the day, about 10 hours afterwards , I got my Iv infusion of this medication . About 10 hours after the IV infusion I became very sick , Flu like symptoms , 103.6 temperture , thought

About 6 weeks after I got Reclast I got pains in my groin and hip. Is that a coincidence or is it possible to have these symptoms so long after the infusions. It is now 5 months and I now have pain in both hips, back and tingling in my feet and one

48 years of age. I was diagnosed with urinary tract infection. Had one dose of monuril 3 gr. After 7 hours developed skin rash on the back, arms and neck, generally swelling of the face, specially below the eyes, Had oral antihistamine and went to

Blurred vision, giddiness,Tiredness,Swelling on feet and hands

I have been Pradaxa for almost a month had severe outbreak of hives on my feet and my legs up to my knees. I also having swelling of legs and feet along with fatigue in joints and body limbs. Doctor changed my Med. but the side effects is still o

<span style='color: #808080;'><b>Describe Your Injection site swelling from INFLUENZA (H1N1) (H1N1 (MONOVALENT) (UNKNOWN)) 2010 Experience Here: I am 46, Female on discharge from hospital 12.6.10 10pm after treatment for acute diverticuli

<span style='color: #808080;'>I just had 5 days of one venofir infusion a day.My hands and arms swelled up like balloons. They are very painful and feel like they are on fire. Ice packs helped the burning sensation but the swelling is still ver

I have experience for cellulitis in my age 14. Now i'm 24 years old. But now My leg is swelling in Night. Morning time is not swelling...I want to answer.

75mg. Hallucinations, inability to speak for 18 hours- trip tp ER- IV diazepam- severe swelling of face, pain EVERYWHERE, horrific dreams for weeks after one dose.

:'(depression as usual...since I started taking Welchol I have had pain in out part of rib cage when try to sleep on left side.....thumb and index finger feel like they are asleep on left side... my ankle on left foot has started swelling....feeling

Abdominal pain, diarrhoea, headache, joint swelling (psoriasis flare), sore eyes, increase in hot flushes.

About a year ago i was suscribed Primperan for my rumination syndrome to stop vomiting and feeling nausea. About one hour after i took my medicin my tounge started rolling and swelling, my teeth chattering and i got cramps in my face. I had to go wit

SWELLING Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Not yet recruiting Cold Magnesium Sulfate Solution for Perineal Swelling Following Vaginal Delivery
Conditions: Vaginal Delivery;   Perineal Swelling;   Perineal Pain
Interventions: Other: Cold pads soaked in Magnesium sulfate solution;   Other: Cold pads soaked in water
Outcome Measures: Reduction in the level of perineal pain;   Reduction in perineal Swelling;   Reduction in hemorrhoids pain and Swelling
2 Recruiting Evaluation of Laryngeal Ultrasonography Performance in Predicting Major Post Extubation Laryngeal Edema in Intensive Care Patients
Conditions: Laryngeal Edema;   Acute Respiratory Failure Requiring Reintubation
Outcome Measures: Performance of laryngeal ultrasonography in predicting major post extubation laryngeal edema in intensive care patients.;   Performance of laryngeal ultrasonography in predicting post-extubation stridor in intensive care patients.;   Frequency of major post-extubation laryngeal edema and post-extubation stridor;   Risk factors of major post-extubation laryngeal edema in intensive care unit;   Evolution of ultrasonic parameters with corticotherapy after reintubation for a major post-extubation laryngeal edema;   Evaluation of impact of major post-extubation laryngeal edema occurence on mechanical ventilation duration, hospitalization duration and mortality in intensive care unit;   Inter-observer reproductibility of ultrasound scanning and ultrasonic air-leak volume measurement
3 Not yet recruiting Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
Conditions: Macular Edema;   Cystoid Macular Edema;   Uveal Melanoma;   Radiation Maculopathy;   Radiation Retinopathy
Interventions: Drug: Ozurdex;   Drug: Bevacizumab
Outcome Measures: Proportion of eyes showing >=2 lines of improvement in best-corrected visual acuity;   Change in central subfield retinal thickness;   Development of glaucoma;   Development of cataract;   Development of retinal detachment;   Development of vitreous hemorrhage
4 Recruiting Intraocular Bevacizumab Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema
Condition: Diabetic Macular Edema
Interventions: Drug: Bevacizumab (Avastin);   Drug: Triamcinolone;   Drug: Sham;   Procedure: Lucentis
Outcome Measures: Efficacy of the treatment assessed with visual acuity measured by ETDRS charts and central retinal thickness as measured by standard Optical Coherence Tomography (OCT);   To explore the structural mechanisms of the effect on diabetic macular edema as assessed by fluorescein angiography and ultra high-resolution optical coherence tomography. To observe the changes in retinal function a microperimetry is assessed.
5 Recruiting Knee Swelling Under Use of Compression Stockings After Outpatient Surgery
Condition: Knee Pain Swelling
Interventions: Other: Patients use compression stockings for 10 days after surgery;   Other: normal therapy - no compression stockings
Outcome Measures: Amount of Swelling of lower Extremity (circumference in mm and volume in ml);   Pain (visual analoge scale) and Range of Movement (degree of flexion)
6 Unknown  Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema
Conditions: Corneal Edema;   Visual Acuity
Interventions: Drug: Brimonidine Tartrate 0.2%;   Drug: Timolol maleate 0.5%
Outcome Measures: central corneal thickness in micrometer;   grading of corneal edema (1-3)
7 Unknown  Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
Conditions: Diabetic Retinopathy;   Macular Edema
Intervention: Drug: Ranibizumab
Outcome Measures: Mean change in Early Treatment for Diabetic Retinopathy Study (ETDRS) eye chart vision.;   Mean number of injections.;   Mean change in spectral domain optical coherence tomography (SD-OCT) central foveal thickness (CFT).;   Percentage of patients with best corrected visual acuity (BCVA) Snellen-equivalent of 20/40 or better.;   Percentage of patients anatomically "dry.";   Number of participants with adverse events as a measure of safety and tolerability.
8 Unknown  Power Spectral Analysis of Breath Sound in Pulmonary Edema
Condition: Pulmonary Edema
Outcome Measure:
9 Recruiting Randomized Trial of Exercise on Lower Extremity Edema After Lymphadenectomy in Gynecologic Cancer
Condition: Gynecologic Cancer
Intervention: Other: Pelvic and lower extremity exercise
Outcome Measures: Change in lower extremity edema-related symptoms after pelvic and lower extremities exercise;   the compliance rate of management guidelines for lower extremity edema, the performance rate for pelvic and lower extremity exercise
10 Recruiting Mild Compression Sock for Control of Lower Extremity Edema in Individuals With Diabetes
Condition: Mild to Moderate Edema of Diabetic Legs
Interventions: Device: mild compression diabetic sock;   Device: Standard diabetic sock
Outcome Measures: lower extremity edema;   lower extremity vascular status;   physical activity level
11 Not yet recruiting OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits
Conditions: Diabetes;   Diabetic Macular Edema;   Diabetic Retinopathy
Intervention: Device: OCT imaging
Outcome Measures: Rates of retina care for patients with diabetic macular edema;   Retinal referral rates for patients with DME;   Rates of retinal treatment for patients with DME;   Rates of retinal treatment over 1 year for patients with DME
12 Unknown  Triple Therapy for Diffuse Diabetic Macular Edema
Condition: Diffuse Diabetic Macular Edema
Intervention: Procedure: Triple therapy for diffuse diabetic macular edema
Outcome Measures: Best-corrected visual acuity (BCVA) and central macular thickness (CMT);   Presence of vitreomacular traction or epimacular membrane, grade of DR, patients age, HbA1c level, BMI, systemic hypertension
13 Not yet recruiting A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME)
Condition: Diabetic Macular Edema
Intervention: Drug: Teprotumumab
Outcome Measure: Safety of RV001in subjects with Diabetic Macular Edema
14 Recruiting A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema
Condition: Macular Edema, Diabetic
Interventions: Drug: Ranibizumab;   Drug: Placebo;   Drug: PF-04634817;   Drug: Masked Sham Therapy
Outcome Measures: Mean Change from Baseline in the Best Corrected Visual Acuity Score;   Proportion of participants gaining 15 ETDRS letters in BCVA from baseline;   Mean changes in central subfield retinal thickness from baseline as assessed by optical coherence tomography (OCT);   Mean changes in the area of fluorescein leakage from baseline by scheduled study visit as assessed by fluorescein angiography (FA);   Mean change in steps of diabetic retinopathy (ETDRS severity scale) from baseline as assessed by digital fundus photography (FP);   The systemic exposure of PF-04634817 in participants with diabetes and macular edema
15 Recruiting Impact of Fluid Resuscitation Therapy on Pulmonary Edema as Measured by Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome (ARDS)
Conditions: Acute Respiratory Distress Syndrome (ARDS);   Hypovolemia;   Pulmonary Edema
Intervention: Drug: hydroxyethyl starch
Outcome Measures: Rate of alveolar fluid clearance;   Extra-vascular lung water;   Pulmonary vascular permeability index;   Global enddiastolic volume index;   mean arterial pressure;   cardiac output;   pulse pressure variation;   stroke volume variation;   central venous venous oxygenation;   central venous pressure;   PaO2;   lung compliance;   airways resistance;   lung injury score;   Plasma levels of sRAGE;   Alveolar levels of sRAGE;   Brain natriuretic peptide levels;   Plasma osmolarity;   Oncotic pressure;   Electrical impedance tomography;   Mortality
16 Recruiting Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema
Conditions: Macular Edema, Cystoid;   Vision Disorders;   Diabetic Macular Edema;   Cystoid Macular Edema Following Cataract Surgery;   Cataract
Interventions: Drug: Dexamethasone Drug delivery system (Ozurdex);   Procedure: Cataract surgery
Outcome Measures: change in the central macular thickness;   Change in the visual acuity
17 Recruiting Characterization of Eyes With Diabetic Macular Edema That Show Different Treatment Response to Intravitreal Anti-VEGF (CHARTRES)
Condition: Diabetic Macular Edema
Outcome Measures: Central Retinal Thickness (Change from screening);   Presence (and location) of cysts in the retinal layers (change from screening);   Presence of OCT diffuse macular edema (without cyst formation) (change from screening);   Presence of neurosensorial retinal detachment. (change from screening);   Degree of integrity of the photoreceptors in the inner/outer segments layer in the 1 mm centered in the fovea (change from screening);   Presence and extension of capillary occlusion (change from screening);   Area of macular leakage (intraretinal fluid volume and retinal thickness) (change frmo screening);   Best Corrected Visual Acuity (BCVA) (Change from screening);   Central Retinal Thickness (change from screening);   Area of macular leakage (intraretinal fluid volume and retinal thickness) (change from screening);   Best Corrected Visual Acuity (change from screening)
18 Unknown  Assessment of Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome
Condition: Bone Marrow Edema
Interventions: Drug: Aclasta;   Drug: Placebo
Outcome Measures: Reduction of the Edema area;   Reduction of pain (VAS);   Quality of life (Qualeffo-41 questionnaire - Quality of life questionnaire of the European Foundation for Osteoporosis);   Subjective estimation of medical condition (PDI);   Number of additional medicinal visits;   Number of days of illness;   Number of Participants with Adverse Events as a Measure of Safety and Tolerability
19 Recruiting Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema
Conditions: Diabetes;   Diabetic Macular Oedema;   Diabetic Macular Edema;   Diabetic Retinopathy
Interventions: Drug: Avastin (Bevacizumab);   Drug: Ozurdex (dexamethasone)
Outcome Measures: Proportion of eyes that have central macular thickness <300 microns 6 months after switching;   Mean change in central macular thickness (CMT) as measured by OCT.
20 Recruiting Prevention and Treatment of Immersion Pulmonary Edema
Conditions: Immersion Pulmonary Edema (IPE);   Swimming Induced Pulmonary Edema (SIPE)
Intervention: Drug: Sildenafil
Outcome Measure: Pulmonary artery pressure during cold water immersion